noom weight loss glp 1 expands its GLP-1 range with 'microdose' package Noom's GLP-1 Companion Receives Major

References 1 PovoleriGAScottCNova-LampertiEAJohnSLombardiGAfzaliB

Prior literature, particularly one other case report, has raised the possibility of an association between GLP-1 agonist use and the development of non-alcoholic Wernickes encephalopathy (NAWE), like our patient [14]

Chobani High Protein Yogurt Drink Calories about 140 to 170 Protein 20 to 30 grams Protein source milk protein Added sugar 0 to about 5 grams (varies by flavor) Fiber 0 grams Sweetener depends on version Price about $2 to $3 A dairy based option that feels more like a traditional food than a typical protein shake

Pregnant or breastfeeding individuals, people planning pregnancy, and those with certain chronic conditions may not be eligible

Reliable Outcomes: Trackable results with strong patient satisfaction

Conservative combination protocol (if attempting) Rationale for conservative approach: No safety data available Both peptides slow gastric emptying significantly Risk of severe GI complications Start low, go slow principle Tirzepatide component: Follow standard FDA-approved titration Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg weekly (or stay at 10mg) Some reach 15mg weekly (maximum) Cagrilintide component (reduced from standard): Start AFTER tirzepatide stabilized at therapeutic dose (week 13+) Week 13-16: 0.6mg weekly (lower than standard) Week 17-20: 1.2mg weekly Week 21-24: 1.8mg weekly (may be maximum tolerable) Consider 2.4mg only if tolerating perfectly Conservative dosing comparison: Why sequential is safer: Tirzepatide establishes baseline first Can attribute new side effects to cagrilintide Easier to manage one variable at a time Option to stop cagrilintide if intolerable Less overwhelming than both simultaneously Expected benefits: 18-25% total weight loss (conservative estimate) Potentially superior to tirzepatide alone (15-22%) But incremental benefit may be modest (3-5% additional) Use SeekPeptides to plan sequential peptide additions safely